Predictive Value in Retinal Vein Occlusions of Early Versus Late or Incomplete Ranibizumab Response Defined by Optical Coherence Tomography
Authors:
- Peter A. CampochiaroPCPeter A. Campochiaro
- Howard ShapiroHSHoward Shapiro
- Roman G. RubioRRRoman G. Rubio
- 1 May 2013
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 120 (5) , 1057-1063
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Ranibizumab for Macular Edema Due to Retinal Vein OcclusionsOphthalmology, 2012
- Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III StudyOphthalmology, 2011
- Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III StudyOphthalmology, 2011
- Ranibizumab for Macular Edema following Branch Retinal Vein OcclusionOphthalmology, 2010
- Ranibizumab for Macular Edema following Central Retinal Vein OcclusionOphthalmology, 2010
- Ranibizumab for Macular Edema Due to Retinal Vein Occlusions: Implication of VEGF as a Critical StimulatorMolecular Therapy, 2008